Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 11
2003 15
2004 19
2005 17
2006 17
2007 17
2008 12
2009 16
2010 19
2011 19
2012 26
2013 25
2014 37
2015 22
2016 37
2017 28
2018 24
2019 35
2020 22
2021 27
2022 23
2023 15
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

438 results

Results by year

Filters applied: . Clear all
Page 1
Is the endotoxin-complement cascade the major driver in lipedema?
Kruglikov IL, Scherer PE. Kruglikov IL, et al. Among authors: scherer pe. Trends Endocrinol Metab. 2024 Apr 29:S1043-2760(24)00087-0. doi: 10.1016/j.tem.2024.04.004. Online ahead of print. Trends Endocrinol Metab. 2024. PMID: 38688780 Review.
Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease.
Wang MY, Zhang Z, Zhao S, Onodera T, Sun XN, Zhu Q, Li C, Li N, Chen S, Paredes M, Gautron L, Charron MJ, Marciano DK, Gordillo R, Drucker DJ, Scherer PE. Wang MY, et al. Among authors: scherer pe. Cell Metab. 2024 Mar 5;36(3):575-597.e7. doi: 10.1016/j.cmet.2023.12.024. Epub 2024 Jan 17. Cell Metab. 2024. PMID: 38237602
Clinical and molecular profiling of human visceral adipose tissue reveals impairment of vascular architecture and remodeling as an early hallmark of dysfunction.
Rosendo-Silva D, Gomes PB, Rodrigues T, Viana S, da Costa AN, Scherer PE, Reis F, Pereira F, Seiça R, Matafome P. Rosendo-Silva D, et al. Among authors: scherer pe. Metabolism. 2024 Apr;153:155788. doi: 10.1016/j.metabol.2024.155788. Epub 2024 Jan 14. Metabolism. 2024. PMID: 38219974 Free article.
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease.
Henriksen K, Genovese F, Reese-Petersen A, Audoly LP, Sun K, Karsdal MA, Scherer PE. Henriksen K, et al. Among authors: scherer pe. Endocr Rev. 2024 May 7;45(3):361-378. doi: 10.1210/endrev/bnad036. Endocr Rev. 2024. PMID: 38091968 Review.
Hyperleptinemia contributes to antipsychotic drug-associated obesity and metabolic disorders.
Zhao S, Lin Q, Xiong W, Li L, Straub L, Zhang D, Zapata R, Zhu Q, Sun XN, Zhang Z, Funcke JB, Li C, Chen S, Zhu Y, Jiang N, Li G, Xu Z, Wyler SC, Wang MY, Bai J, Han X, Kusminski CM, Zhang N, An Z, Elmquist JK, Osborn O, Liu C, Scherer PE. Zhao S, et al. Among authors: scherer pe. Sci Transl Med. 2023 Nov 22;15(723):eade8460. doi: 10.1126/scitranslmed.ade8460. Epub 2023 Nov 22. Sci Transl Med. 2023. PMID: 37992151
Leptin Reduction as a Required Component for Weight Loss.
Zhao S, Li N, Xiong W, Li G, He S, Zhang Z, Zhu Q, Jiang N, Ikejiofor C, Zhu Y, Wang MY, Han X, Zhang N, Solis-Herrera C, Kusminski C, An Z, Elmquist JK, Scherer PE. Zhao S, et al. Among authors: scherer pe. Diabetes. 2024 Feb 1;73(2):197-210. doi: 10.2337/db23-0571. Diabetes. 2024. PMID: 37935033
438 results